Abhijit Banerjee is a Professor in the Department of Economics at the Massachusetts Institute of Technology (MIT). His research focuses on development economics, public health policy, and social protection programs, particularly addressing poverty and inequality in low- and middle-income countries. He has conducted large-scale experiments evaluating interventions such as conditional cash transfers, universal basic income, and healthcare policies. Key areas of interest include the design and implementation of anti-poverty programs, behavioral economics, and the long-term health impacts of infectious diseases like COVID-19. His work often integrates experimental methods to assess policy effectiveness, with contributions to global health studies and economic development strategies. Notably, his research on the RECOVERY trial evaluates treatments for hospitalized COVID-19 patients, while other studies explore financial spillover effects of electronic government transfers in Indonesia and savings behavior interventions in Chile. Banerjee has collaborated on projects analyzing post-COVID-19 health outcomes, labor market dynamics in India, and the role of trusted messengers in public health communication during crises. Despite the breadth of his contributions, specific details about his educational background, grants, or lab affiliations are not explicitly provided in the source text.
Professor Hutan Ashrafian is a clinician-scientist and surgeon at the University of Leeds Business School, holding dual roles as Professor of Research Impact and Senior Research Fellow at Imperial College London. His expertise spans AI in healthcare, metabolic surgery, and ancient history. He pioneered STARD-AI and QUADAS-AI guidelines for AI diagnostics, collaborated on AI-driven breast cancer screening with Google and NHS, and led global health policy initiatives. Ashrafian’s work bridges medicine, history, and philosophy, including his contributions to understanding historical figures’ medical conditions, such as King Tutankhamun’s epilepsy. He has authored over 550 publications, 12 books, and holds a PhD in computational physiology and an MBA with distinction. Awards include the Hunterian Prize and Wellcome Trust Fellowship. His research also explores AI ethics, quantum physics paradoxes, and art-based medical diagnostics. Education: PhD in Computational Physiology (Imperial College London) MBA (Warwick Business School) MD (University College London) Bachelor of Science in Immunology (University College London) Research Interests: Ashrafian’s work spans: AI in Medicine: Diagnostic algorithms, guideline development (STARD-AI/QUADAS-AI), and ethical frameworks. Metabolic Surgery: Bariatric interventions, gut microbiome, and obesity treatments. Ancient History: Medical analyses of historical figures (e.g., Tutankhamun, Julius Caesar) and art-based pathology identification. Philosophy: AI rights (AIONAI law), temporal paradoxes, and the Simulation Argument. Awards: Royal College of Surgeons Arris and Gale Lectureship Hunterian Prize Wellcome Trust Research Fellowship Advising & Innovation: Supervised >50 PhD students, co-founded Oxford Medical Products (weight loss tech), and serves as CSO at Flagship Pioneering’s Preemptive Health division. He advises on NHS digital transformation and global health policy. Labs/Teams: Leads AI initiatives at Imperial’s Institute of Global Health Innovation and collaborates with Google, NICE, and international institutions on health tech solutions.
Polina Golland is a Professor in the Department of Electrical Engineering and Computer Science (EECS) at MIT and a Principal Investigator in the Computer Science and Artificial Intelligence Laboratory (CSAIL). Her research focuses on developing novel techniques for biomedical image analysis and understanding, particularly in medical vision, AI/ML, and health care applications. She leads the Medical Vision Group and collaborates with the Vision Group at CSAIL. Her work emphasizes statistical modeling of medical images, shape modeling, and predictive analytics for biological processes. Current projects include fetal MRI analysis, cardiac MRI segmentation, and quantitative assessment of pulmonary edema in chest X-rays. She has secured grants from NIH, MIT-IBM Watson AI Lab, and other institutions to support her research. Dr. Golland teaches courses on inference, probability, and probabilistic systems. She advises graduate students in MIT's EECS program and has mentored numerous postdocs and researchers. Her lab focuses on translating advanced imaging techniques into clinical workflows, with applications in neuroimaging, fetal health monitoring, and cardiovascular disease analysis. Notable collaborations include work with Harvard Medical School affiliates, Brigham and Women's Hospital, and the MIT Jameel Clinic. Her research aims to bridge computational methods with clinical needs, improving diagnostic tools and treatment planning through machine learning and medical imaging innovation.
Dr. Carolyn Emery is a Professor in the Faculty of Kinesiology at the University of Calgary, with joint appointments in Pediatrics and Community Health Sciences at the Cumming School of Medicine. She holds leadership roles as Chair of the Sport Injury Prevention Research Centre (an International Olympic Committee Research Centre) and the Alberta Children’s Hospital Research Institute. Her affiliations include the McCaig Institute for Bone and Joint Health, Hotchkiss Brain Institute, and O’Brien Institute for Public Health. Dr. Emery’s education includes a BScPT from Queen’s University (1988), MSc in Epidemiology from the University of Calgary (1999), and PhD in Epidemiology from the University of Alberta (2004). Her research focuses on injury prevention in youth sports, concussion, and pediatric rehabilitation, aiming to reduce long-term health consequences such as osteoarthritis and post-concussion syndrome. She leads major grants including CIHR’s “SHRed Injuries” and NFL-funded concussion surveillance programs. Her research interests emphasize practical interventions for injury prevention, including neuromuscular training and policy changes. Recent work explores concussion outcomes in adolescents, biomechanical injury mechanisms, and global sport safety initiatives. She has published extensively on topics like sport-related musculoskeletal injuries, concussion management, and the epidemiology of youth sports. Dr. Emery has received over 20 awards, including the Royal Society of Canada Fellowship, Killam Professorship, and CIHR Canada Research Chair. Her work bridges clinical practice, policy, and community engagement to enhance public health outcomes in sports and youth recreation. Her lab, the Sport Injury Prevention Research Centre, collaborates internationally to develop evidence-based strategies for injury prevention. Current projects include evaluating the impact of tackle laws in rugby, head acceleration in wrestling, and long-term consequences of pediatric concussions.
Didier Trono is a Full Professor at École Polytechnique Fédérale de Lausanne (EPFL), where he leads the Laboratory of Virology and Genetics (LVG) within the School of Life Sciences. Formerly, from 2004 to 2012, he served as the founding dean of EPFL's Faculty of Life Sciences, orchestrating its development and growth during this formative period. Trono received his medical education at the University of Geneva, followed by clinical training in pathology, internal medicine, and infectious diseases in Geneva and at Massachusetts General Hospital in Boston. His scientific career began at the Whitehead Institute of MIT, and in 1990 he was recruited by the Salk Institute of San Diego to launch an AIDS research center. After seven years in the United States, he returned to Europe and eventually joined EPFL. Dr. Trono's research has evolved significantly over his career. Initially focusing on virus-host interactions, he studied pathogens like HIV and Hepatitis B virus, creating HIV-derived genetic transfer tools that are now successfully used in gene therapy. For approximately the last fifteen years, his research has centered on epigenetics, particularly exploring the impact of retroelements and their control mechanisms on development and physiology of higher organisms, including humans. His laboratory investigates how transposable elements and KRAB zinc finger proteins regulate gene expression, with important implications for understanding cancer biology and developing new diagnostic and therapeutic approaches. Analysis of his recent publications (2022-2024) reveals a strong focus on transposable elements, KRAB zinc finger proteins, and their roles in gene regulation and cancer. His work combines molecular biology, genomics, and bioinformatics approaches to understand how these ancient viral remnants have been co-opted by the host genome to regulate development and cellular functions. The research spans basic molecular mechanisms to potential clinical applications in cancer diagnosis and therapy, with some recent work also addressing SARS-CoV-2 and immune responses. Throughout his career, Professor Trono has mentored numerous PhD students, including Bojkowska Karolina, Brandão Sanches Vong Martins Filipe Amândio, Bulliard Yannick, Coluccio Andrea, Corsinotti Andrea, Coudray Alexandre, De Tribolet-Hardy Jonas Caspar, and Dorschel Iris Arianna. His laboratory has received significant funding to support research at the intersection of virology, genetics, and epigenetics, contributing to EPFL's reputation as a leading institution in life sciences research. The Trono Laboratory continues to be at the forefront of research on retroelements and their regulatory mechanisms, maintaining a vibrant research environment that bridges fundamental biological questions with potential medical applications, particularly in cancer research and precision medicine.
Professor Maria Craig is a distinguished academic and researcher at the University of New South Wales, Faculty of Medicine & Health, specializing in childhood diabetes research. She holds a prominent position as a Professor with extensive contributions to the field of pediatric endocrinology and diabetes, particularly focusing on type 1 diabetes in children. Professor Craig's educational background includes: MB BS from the University of Melbourne MMedSc(ClinEpid) from the University of Newcastle PhD from the University of Sydney FRACP (Fellow of the Royal Australasian College of Physicians) Professor Craig's research primarily focuses on childhood diabetes, with special emphasis on prediction and prevention of type 1 diabetes. She has a significant interest in the association between viruses and type 1 diabetes, collaborating with the Virology Research Group at Prince of Wales Hospital (POWH). Together with Professor Bill Rawlinson, she leads the viral theme for the multicentre ENDIA study (endia.org.au). As principal investigator for the CoRD trial, she is conducting a world-first phase 1 study using autologous cord blood for prevention of type 1 diabetes in children with islet autoimmunity. Additionally, she serves as principal investigator for the Australasian Diabetes Data Network (ADDN). Her research portfolio also encompasses the epidemiology of various forms of childhood diabetes (type 1, type 2, cystic fibrosis related diabetes and monogenic diabetes) and diabetes complications, in collaboration with Professor Kim Donaghue at the Children's Hospital at Westmead. Professor Craig's extensive publication record, including over 361 journal articles, demonstrates her leadership in advancing our understanding of childhood diabetes. Her recent work shows increasing focus on early detection methods, risk prediction models, technological interventions for diabetes management, and the complex interplay between viral infections and autoimmune diabetes development. She has been instrumental in developing clinical practice guidelines through her role as co-editor of the International Society for Pediatric and Adolescent Diabetes (ISPAD) guidelines. Professor Craig has received numerous prestigious awards recognizing her contributions to pediatric endocrinology and diabetes research: Australian Paediatric Endocrine Group Young Investigator's Award (1997) Asia Pacific Paediatric Endocrine Society Clinical Teaching Award (2008) Lifetime Honorary Member, Caring and Living as Neighbours (2013) Australian Diabetes Society Jeff Flack Diabetes Data Award (2019) Australian Paediatric Endocrine Group Norman Wettenhall Award for Research and Innovation (2019) Throughout her career, Professor Craig has demonstrated exceptional leadership in professional societies, having served as former president/treasurer of the Australasian Paediatric Endocrine Group (APEG) and currently as Scientific Convenor of the Asia Pacific Paediatric Endocrine Society Fellows school. Her work with the ENDIA study and Australasian Diabetes Data Network represents significant collaborative research efforts involving multiple institutions across Australia and internationally. Her principal investigator roles for major studies indicate substantial research funding support. Professor Craig leads several important research initiatives including the ENDIA study, the CoRD trial, and the Australasian Diabetes Data Network. These programs involve multidisciplinary teams of researchers, clinicians, and support staff working collaboratively to advance understanding and treatment of childhood diabetes. Her work at the intersection of virology and diabetes represents a unique and innovative approach to understanding the environmental triggers of type 1 diabetes.
Rolf Halden is a Professor and Center Director at Arizona State University, holding appointments in the School of Sustainable Engineering and the Built Environment, the Biodesign Center for Environmental Health Engineering, and the Global Futures Scientists and Scholars program. He is a leading expert in environmental health engineering, wastewater-based epidemiology, and bioremediation. Education: Ph.D. in Civil (Environmental) Engineering, University of Minnesota (1997) M.S. in Civil (Environmental) Engineering, University of Minnesota (1994) M.S. in Biology, Technical University of Braunschweig, Germany (1992) Postdoctoral Fellow, Environmental Science, Lawrence Livermore National Laboratory (1998) Research Focus: Halden’s research integrates environmental chemistry, public health, and sustainability to understand how anthropogenic chemicals affect ecological and human health. His lab uses advanced mass spectrometry (LC-MS/MS, MALDI-TOF) to track pollutants such as PPCPs, microplastics, pesticides, and dioxins across air, water, soil, and biological systems. He pioneered the use of wastewater treatment plants as public health observatories, enabling real-time tracking of disease, drug use, and environmental exposures. Scientific Awards & Recognition: Leadership Award, Arizona State University (2018) Rocky Mountain Emmy Award (2018) Leroy E. Burney Lecturer, Johns Hopkins School of Public Health (2011) ACS Expert Program Member (2014–present) NIEHS Superfund R01 Working Group National Leader (2012–2014) Labs & Teams: Halden is the Founding Director of the Biodesign Center for Environmental Health Engineering at ASU, where he leads a multidisciplinary team focused on environmental proteomics, bioremediation, and diagnostic tool development. He also co-leads the Human Health Observatory , a national wastewater monitoring network. Grants & Funding: Halden has secured major funding from NSF, NIH, EPA, DoD, and private industry. Notable projects include the development of in-situ groundwater monitoring devices, national wastewater surveillance of SARS-CoV-2, and studies on microplastics and neurodegenerative disease.
Byron Wallace is the Sy and Laurie Sternberg Interdisciplinary Associate Professor at Northeastern University's Khoury College of Computer Sciences, where he also serves as Associate Dean for Research and Director of the BS in Data Science Program. His research focuses on Natural Language Processing and Machine Learning applications in healthcare. Education Details of formal education are not explicitly provided in the available text, though he holds a PhD from Tufts University (mentioned in thesis award context). Research Interests His work centers on developing NLP and ML models for health applications, with particular emphasis on: Biomedical evidence synthesis automation Electronic Health Record processing Model interpretability and trustworthiness Human-in-the-loop systems Learning with limited supervision Research Trends Recent publications demonstrate strong focus on large language model applications in healthcare, including factuality evaluation for medical summarization, evidence extraction from clinical trials, and interpretable risk prediction models. Notable contributions include work on GPT-3 applications in medical evidence synthesis and neural methods for EHR analysis. Scientific Awards ACL Outstanding Paper Award (2022) ICLR Spotlight (top 5% acceptance) (2024) Best Student-led Paper Award at AMIA 2021 NSF CAREER Award (2018-2023) Advising and Grants Currently advises 4 PhD students and has mentored numerous others. Major funding includes: NSF CAREER Award ($500K+) NIH R01 grant for EHR summarization NSF Medium grant for healthcare summarization Support from Army Research Office, Amazon, and Seton Hospital Labs and Teams Leads the Evidence Inference project team working on automated biomedical evidence synthesis. Collaborates with Brigham and Women's Hospital, Mass General Hospital, and Reboot Rx for clinical translation of research.
Dr. Jimeng Sun is a Health Innovation Professor at the Siebel School of Computing and Data Science and Carle Illinois College of Medicine at the University of Illinois Urbana-Champaign. Co-founder of Keiji AI , he leads groundbreaking research at the intersection of artificial intelligence and healthcare, actively deploying clinical AI systems and developing frameworks like PyHealth and Therapeutics Data Commons . His research spans four major areas: Clinical AI Systems : Developing interpretable models (e.g., RETAIN) for patient similarity, temporal event prediction, medication recommendation, and clinical outcome forecasting Drug Discovery : Creating molecular optimization frameworks, drug-target interaction models, and AI-driven platforms Clinical Trials : Pioneering patient-trial matching, outcome prediction, and optimization frameworks using deep learning and graph neural networks Biosignal Analysis : Advancing sleep staging, seizure classification, and automated EEG/Cardiac monitoring systems With over 500 top-tier publications (including in Nature , NEJM AI , and leading AI conferences) and an h-index of 99, his work has been recognized with the Top 100 AI Leaders in Drug Discovery and Advanced Healthcare award. He maintains active collaborations with institutions like Massachusetts General Hospital , Medidata Solutions , and OSF Healthcare . His recent publications reveal a strong focus on: Reinforcement learning applications in medical data analysis Large language model adaptation for clinical tasks Knowledge graph integration with AI systems Synthetic data generation for healthcare Multi-modal learning in clinical contexts Explainable AI for medical applications Dr. Sun's lab ( Sunlab ) emphasizes practical impact over theoretical work, actively collaborating with hospitals and healthtech companies. He welcomes contributions from clinicians, researchers, and industry partners through initiatives like his AI for Health webinar series .
Dr. Melanie Franklin is a pediatric psychologist at Children's Hospital of Philadelphia with expertise in sleep disorders, treatment adherence, and pediatric psychology. She operates within the Department of Child and Adolescent Psychiatry and Behavioral Sciences and collaborates across multiple teams. BA in Psychology – Muhlenberg College PhD in School Psychology – Lehigh University Residency and Fellowship in Pediatric Psychology – Nemours/A.I. DuPont Children’s Hospital Her research focuses on: Sleep behavior in chronic illness populations Mental health communication barriers ADHD functional outcomes Treatment adherence strategies Recent publications demonstrate expertise in ADHD comorbidities , Cystic Fibrosis sleep interventions , and academic functioning analysis . Key collaborations include: Psychiatry and Behavioral Sciences Sleep Center Pulmonary and Sleep Medicine Division
John Oakey is a Professor and Graduate Coordinator in the Department of Chemical and Biomedical Engineering at the University of Wyoming, with additional affiliations to the INBRE Program, Molecular and Cellular Life Sciences Program, and Materials Science and Engineering Program. Education Postdoctoral Fellow, Center for Engineering in Medicine, Massachusetts General Hospital & Harvard Medical School (2007–2010) Ph.D. Chemical Engineering, Colorado School of Mines (2003) M.S. Chemical Engineering, Colorado School of Mines (1999) B.S. Chemical Engineering, Penn State University (1997) Research Interests Oakey’s laboratory integrates fluid dynamics, colloidal science and materials science to understand how biological systems behave under flow, on surfaces and within complex 3-D geometries. A unifying theme is the use of microfabrication and microfluidics to create new diagnostic, prognostic and therapeutic platforms. Current thrusts include: Heterogeneous biomaterials: self-assembled particulate tissue scaffolds whose mechanical and transport properties can be temporally programmed. Inertial microfluidics: exploiting lift forces for membrane-free particle sorting, enrichment and diagnostics. Multi-temporal analysis by flow cytometry: development of closed-loop, high-throughput microfluidic cytometers for longitudinal single-cell studies. Publication Trends From 2025 back to 2010, Oakey’s articles reveal a consistent trajectory that marries fundamental physics (microtubule mechanics, inertial focusing) with translational applications (cell encapsulation, tissue scaffolds, drug delivery). Recent work (2023-2025) increasingly targets injectable granular hydrogels, single-cell therapeutic delivery and sustainable carbon-sequestering living materials, demonstrating an evolution from microscale transport phenomena to macroscopic biomedical and environmental impact. Scientific Awards No named awards are listed in the supplied text. Advising & Coordination Roles As Graduate Coordinator for the Department of Chemical and Biomedical Engineering, Professor Oakey oversees graduate program development and student mentoring. While no individual students are named, his role implies active supervision of M.S. and Ph.D. advisees in chemical and biomedical engineering. Laboratory & Teams The Oakey Research Group operates from the Energy and Environmental Research Building (EERB 435A) at the University of Wyoming. The lab enjoys R1-level research infrastructure and collaborates broadly with the Wyoming INBRE network, the Molecular and Cellular Life Sciences Program, and the Materials Science and Engineering Program.
Anna S. Mattila is the Marriott Professor of Lodging Management and serves as Professor-in-Charge of the Graduate Program at the School of Hospitality Management, Pennsylvania State University. Her research spans social media, service recovery, servicescape, prosocial behaviors, cross-cultural studies, and wellness in hospitality contexts. Education : B.S. and Ph.D. from Cornell University, M.B.A. from University of Hartford Mattila's work examines how emotions, cultural norms, and technological innovations like AI influence consumer decisions in hospitality. Her studies cover topics from robotic service interactions to sustainable food marketing and moral psychology in tourism. She has published extensively in journals such as International Journal of Hospitality Management and Journal of Consumer Marketing . Her recent articles focus on AI integration in hospitality, consumer trust in virtual influencers, upcycled food adoption, and the psychological effects of servicescape design. Key themes include ethical consumption, digital transformation, and cross-cultural consumer behavior. Advising : Supervised Anqi Luo's dissertation on service recovery in 2022 Mattila's office is located in 224 Mateer Building, University Park, PA. She contributes to advancing hospitality research through methodological consulting and the Penn State Biomarker Core Laboratory.
Dr. Catherine Legault serves as an Assistant Professor in the Department of Neurology and Neurosurgery at McGill University and Co-director of the Stroke Programme at the McGill University Health Centre. She is a neurologist at The Neuro (Montreal Neurological Institute-Hospital), a bilingual academic healthcare institution and part of McGill's Neuroscience Mission. Her educational background includes: Medical degree from McGill University (2011) Internship in Internal Medicine at Montreal’s Jewish General Hospital Neurology Residency at The Neuro (2012-2015) with chief residency (2014-2015) Vascular Neurology fellowship at Stanford University NIH StrokeNet fellowship Dr. Legault's clinical research focuses on translational stroke care, emphasizing acute interventions, rehabilitation innovation, and systems optimization. Her work integrates wearable technology with traditional stroke recovery methods while addressing post-stroke cognitive and visual impairments. She actively develops patient-centered educational frameworks and investigates hemodynamic interventions like induced hypertension. As principal investigator for multiple stroke clinical trials at The Neuro's Clinical Research Unit, she bridges bench-to-bedside research. Her teaching spans emergency consultations, bedside clinical supervision, and outpatient stroke clinics for residents and medical students. Through multidisciplinary collaboration in the Stroke Programme, Dr. Legault advances integrated care models that connect acute treatment with long-term rehabilitation, focusing on measurable functional outcomes and healthcare system efficiency.
Eric Schneider is a Professor of Economic History at the London School of Economics and Political Science (LSE), where he has worked since 2015. He serves as Co-Director of the LSE Historical Economic Demography (HED) Group and is a Research Fellow at the Centre for Economic Policy Research (CEPR). His research focuses on health and historical economic demography, including children’s health and growth, early life health outcomes, and fertility differentials in early modern England. He holds a BA in History from the University of Puget Sound, an MPhil in Economic and Social History from the University of Oxford, and a PhD from Nuffield College (Oxford). His research spans topics such as child stunting, nutritional status, and the long-run effects of historical health shocks. Notable projects include analyzing child growth patterns across global contexts and studying the impact of the Second World War on Japanese children’s health. His work frequently employs interdisciplinary approaches, combining historical data with demographic and economic methodologies. Recent publications include studies on smallpox case fatality rates, child health in London’s Foundling Hospital, and the effects of war-induced nutritional stress in Japan. His articles frequently appear in journals like the Journal of Economic Surveys , Population and Development Review , and Explorations in Economic History . Dr. Schneider is involved in academic networks such as the London Universities Population Seminar and teaches courses on economic history, health history, and population dynamics. His work contributes to understanding how historical health and demographic trends shape long-term economic growth and societal development.
Professor Peter Boxall is a Chair in Human Resource Management at the University of Auckland Business School, Department of Management & International Business. He holds a PhD from Monash University and an MCom from the University of Auckland. His research focuses on strategic human resource management and work-related well-being, with notable contributions to understanding high-involvement work systems and HR analytics. He has held visiting professorships at Leeds, Tilburg, and Toulouse, among others. His roles include Associate Dean (Research and PBRF) and leadership in editorial boards for journals like Human Resource Management Journal . Notable awards include the 2023 Distinguished Fellow of HRNZ and multiple Emerald Awards. He teaches courses such as MGMT 304 HR Policy and Practice and supervises PhD students in HRM. His work emphasizes bridging HR practices with organizational and societal outcomes. Education: PhD (Monash), MCom (Auckland), Distinguished Fellow HRNZ Visiting Roles: Leeds, Tilburg, Toulouse, Bath Editorial Roles: Asia Pacific Journal of Human Resources, Human Resource Management Journal His research addresses strategic HRM’s role in organizational success and its impact on employee well-being. Recent studies explore HR analytics, lean production effects, and Industrie 4.0 implications. Awards highlight his scholarly contributions and industry impact. Administrative leadership includes overseeing research initiatives and PBRF evaluations at the Business School. Awards: 2023 Distinguished Fellow, 2020 Emerald Literati Award Teaching: MGMT 223, MGMT 304, GLMI 705
